Rat uterine complement C3 expression as a model for progesterone receptor modulators: Characterization of the new progestin trimegestone

Journal of Steroid Biochemistry and Molecular Biology

Volumn 78, Issue 2, 2001, Pages 137-143

  Lundeen, Scott G ^a   Zhang, Zhiming ^a   Zhu, Yuan ^a   Carver, Jeffrey M ^a   Winneker, Richard C ^a  

^a WYETH AYERST RESEARCH   (United States)

Author keywords

Complement component C3; Endometrium; Progestin; Trimegestone

Indexed keywords

COMPLEMENT COMPONENT C3; DEXAMETHASONE; ETHINYLESTRADIOL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; METHYLTESTOSTERONE; MIFEPRISTONE; PROGESTERONE; PROGESTERONE DERIVATIVE; TRIMEGESTONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DECIDUALIZATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; ENDOMETRIUM; FEMALE; NONHUMAN; OVULATION INHIBITION; PROTEIN EXPRESSION; RAT; UTERUS;

ANIMALS; BIOLOGICAL ASSAY; COMPLEMENT C3; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR MODULATORS; FEMALE; MEDROXYPROGESTERONE; PROGESTERONE CONGENERS; PROGESTINS; PROMEGESTONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROGESTERONE; RNA, MESSENGER; UTERUS;

EID: 0034822884     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(01)00091-7     Document Type: Article

References (25)

1. Hormonal control of ovoimplantation
2. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities
3. Progesterone regulation of heparin-binding epidermal growth factor-like growth factor gene expression during sensitization and decidualization in the rat uterus: Effects of the antiprogestin, ZK98299
4. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
5. Effects of hormone replacement therapy on bone mineral density. Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
6. The assay of progestin
7. The antiovulatory activity of progesterone antagonists is not correlated to their antiprogestational potency in the rat
8. The pharmacological profile of a novel norpregnane progestin (trimegestone)
9. The effects of various steroids on the vaginal histology in the rat
10. Estrogen regulation of tissue specific expression of complement C3
11. Progesterone regulation of estradiol-induced rat uterine secretory protein, complement C3
12. Progesterone and RU486 regulation of uterine complement C3 after prior induction with estradiol
13. The stimulation of uterine complement component C3 gene expression by antiestrogens
14. Glucocorticoid and progestin regulation of eosinophil chemotactic factor and complement C3 in the estrogen-treated rat uterus
15. Complement C3 synthesis, peroxidase activity and eosinophil chemotaxis in the rat uterus: Effect of estradiol and testosterone
16. RU 38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation
17. In vitro characterization of trimegestone: A new potent and selective steroid progestin
18. Implantation and decidualization in rodents
19. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors
20. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor
21. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism
22. Stromal estrogen receptors (ER) mediate the mitogenic effect of estradiol on uterine epithelium